News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AltaRex Medical Corp. (ALXMF.PK) Signs Distribution Agreement With Dompe


10/19/2005 5:08:56 PM

AltaRex Medical Corp. (TSX:ALT) ("AltaRex" or the "Company") today announced that the Company has signed an exclusive distribution agreement (the "Agreement") with Dompe International S.A. (Lausanne, Switzerland) ("Dompe") for its lead product OvaRex(R) MAb. The territory of the Agreement includes Italy, Spain, Portugal, Hungary, Poland, Czech Republic, Switzerland, Austria as well as other Eastern European countries. The Agreement grants Dompe certain rights of first refusal for certain additional cancer antibodies in the territory such as BrevaRex(R), AR 54, ProstaRex(R) and GivaRex(R). The Agreement resulted from a memorandum of understanding (the "MOU") entered into between AltaRex and Dompe on November 16, 2000.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES